Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NatRevImmunol
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NatRevImmunol
-
Prikvačeni tweet
The Feb issue of NRI has set sail: https://go.nature.com/3b4OOMv Avast pipetting ye lab-lubbers and harken to tales of P-aRrr-aRrrs! https://rdcu.be/b01H5
#immunology#inflammation#DAMPs#TLRspic.twitter.com/PvX477igsh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are always very thankful for the detailed insights from our excellent peer reviewers and really appreciate the time taken.https://twitter.com/ordovas_phd/status/1225020547328856065 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nature Rev Immunol proslijedio/la je Tweet
Mucosal
#IgA responses occur in an increasingly complex humoral defence network that also encompasses IgM, IgG and IgD. To know more check out our latest review on@NatRevImmunol.@ekgrasset , Kang Cheng and Andrea Cerutti.#notonlyIgA#IgDmatters#newkidsontheblockhttps://twitter.com/NatRevImmunol/status/1224444457208049667 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For
#WorldCancerDay2020
we bring you recent Reviews on nanomedicine-based immunotherapies by Darrell Irvine and Eric Dane @MIT https://rdcu.be/b1bFp and the roles of B cells and antibodies in the tumour environment by Dmitriy Chudakov and colleagues https://rdcu.be/b1bFDHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nature Rev Immunol proslijedio/la je Tweet
Interested in an editorial career with
@NatureComms in the field of#immunology? We are now hiring a new associate or senior editor, to be based in London or New York. Learn more & apply before Feb 17: https://go.nature.com/36BwJSq pic.twitter.com/qercxe5dbg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA http://dlvr.it/RPKBZG pic.twitter.com/UgwcR3n241
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nature Rev Immunol proslijedio/la je Tweet
How can we advance the development of immunotherapies? In this perspective we outline how single-cell genomics can revolutionize drug development. By
@IdoYofe together with@DahanLab now@NatureMedicine. (1/6) https://www.nature.com/articles/s41591-019-0736-4 …pic.twitter.com/ga8NNI9cKO
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nature Rev Immunol proslijedio/la je Tweet
#NEWinNRU Comment by@VStavrinides et al on mycobacterial#immunotherapy for#ProstateCancer, highlighting current evidence of safety and efficacy of new mycobacterial agents and encouraging a new look at this concept https://go.nature.com/2GymgNj@mrsprostatepic.twitter.com/Vcx7qXD3yF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
'Shocking HIV out of hiding' Back-to-back reports in Nature describe two different approaches to induce robust and reproducible disruption of HIV latency https://rdcu.be/b08IE pic.twitter.com/A4an9bZaDL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NEW Review: Distribution and storage of inflammatory memory in barrier tissues
@ordovas_phd@shaleklab https://go.nature.com/2RVTJYp pic.twitter.com/x5ZQZtIGZv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A recent Progress article highlights insights into the role of exosomal PDL1 in immune oncology and how it may be useful as a biomarker for the management of cancer
@DhouhaDaassi https://go.nature.com/2SisR3G pic.twitter.com/XYtPQkquVt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Distribution and storage of inflammatory memory in barrier tissues http://dlvr.it/RPHWHL pic.twitter.com/phjD1pcuBv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Nature Rev Immunol proslijedio/la je Tweet
#Host_Microbiota_Interactions in#InflammatoryBowel_Disease | Beneficial effects of Symbionts and Dysbiosis in IBD | Gabriel Núñez@umichmedicine@NatRevImmunol https://buff.ly/31eEHjB pic.twitter.com/Z5mOWRoSl2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Host–microbiota interactions in inflammatory bowel disease http://dlvr.it/RP8DSt pic.twitter.com/VBUUmBXIJ0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Enhancing cancer immunotherapy with nanomedicine http://dlvr.it/RP78Ms pic.twitter.com/yjtvTDPkiW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nature Rev Immunol proslijedio/la je Tweet
#B_cells in the#Tumor_Microenvironment |#PlasmaCells and#AntibodyRepertoires | IgG1-biased over IgG3-biased | Dmitriy Chudakov#PrivolzhskyResearch@NatRevImmunol https://buff.ly/2vuT0Vv pic.twitter.com/o6Nr1UYAnr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Intestinal protection without T cell helphttp://dlvr.it/RNz5kJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nature Rev Immunol proslijedio/la je Tweet
Did you know that small vesicles (i.e. exosomes) expressing PD-L1 can be a useful biomarker for
#immunotherapy? Check out this recent review in@NatRevImmunol by some of the pioneers in immunotherapy: https://go.nature.com/2vv7G6T ___#cancer#AcademicTwitter#immunity@DanaFarberpic.twitter.com/iluOlur38b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nature Rev Immunol proslijedio/la je Tweet
#IMMUNOTHERAPY | A GREAT MONTH OF PUBLICATIONS FOR B-LYMPHOMANIACS
| & now super overview @NatRevImmunol
| @CelentyxLtd |https://www.nature.com/articles/s41577-019-0257-x …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.